ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

EXAI Exscientia PLC

4,95
0,00 (0,00%)
Pré-mercado
Última atualização: 05:08:17
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Exscientia PLC EXAI NASDAQ Recibo de Depósito
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 4,95 05:08:17
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,95
mais cotações »

Notícias Recentes

Data Hora Fonte Título
21/03/202408:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
21/03/202408:00BWExscientia Business and Financial Update for the Full Year..
14/03/202412:29BWExscientia berichtet am 21. März 2024 über die..
14/03/202408:00BWExscientia to Report Full Year 2023 Financial Results on..
29/02/202410:20BWExscientia präsentiert auf kommenden Investorenkonferenzen..
28/02/202411:08BWExscientia participera à de prochaines conférences..
28/02/202409:00BWExscientia to Present at Upcoming Investor Conferences in..
07/02/202415:45BWExscientia lance une étude clinique pour approfondir..
07/02/202409:00BWExscientia Initiates Clinical Study to Further Evaluate..
02/01/202412:36BWLe professeur Andrew L. Hopkins est nommé Commandeur de..
02/01/202412:28BWProfessor Andrew L. Hopkins zum Commander of the Order of..
02/01/202409:00BWProfessor Andrew L. Hopkins appointed Commander of the Order..
21/12/202315:09BWExscientia annonce une extension de sa collaboration..
21/12/202311:45BWExscientia gibt die Ausweitung der aktuellen Zusammenarbeit..
21/12/202309:00BWExscientia Announces Expansion of its Current Collaboration..
05/12/202315:54BWExscientia reçoit une subvention d’Open Philanthropy pour..
05/12/202314:11BWExscientia erhält Zuschüsse von Open Philanthropy zur..
05/12/202309:00BWExscientia Receives Open Philanthropy Grant to Explore New..
21/11/202316:26BWExscientia präsentiert sich auf der 6. Jahreskonferenz..
21/11/202313:52BWExscientia participera à la 6e conférence annuelle Evercore..
21/11/202309:00BWExscientia to Present at the 6th Annual Evercore ISI..
09/11/202309:00BWExscientia Business Update for Third Quarter 2023
02/11/202313:36BWExscientia meldet am 9. November 2023 Finanzergebnisse für..
02/11/202308:00BWExscientia to Report Third Quarter 2023 Financial Results on..
17/10/202313:01BWParker Moss rejoint Exscientia au poste de VP exécutif,..
17/10/202313:00BWParker Moss kommt als EVP, Corporate Development, zu..
17/10/202308:00BWParker Moss to Join Exscientia as EVP, Corporate Development
16/10/202315:10BWExscientia präsentiert auf dem ESMO 2023 neue präklinische..
16/10/202308:00BWExscientia to Present New Preclinical Data for AI-designed..
03/10/202317:37BWExscientia detailliert Strategie zur Pipeline-Priorisierung
03/10/202316:12BWExscientia explique sa stratégie de hiérarchisation des..
03/10/202309:00BWExscientia Details Pipeline Prioritisation Strategy
20/09/202309:43BWExscientia beginnt KI-Zusammenarbeit im Bereich Drug..
20/09/202307:47DJNExscientia Shares Rally Premarket on Lucrative Merck Deal
20/09/202307:13BWExscientia annonce une collaboration avec Merck KGaA,..
20/09/202302:00BWExscientia Announces AI Drug Discovery Collaboration with..
31/08/202313:23BWExscientia hält Vortrag bei Investorenkonferenzen im..
31/08/202310:37BWExscientia effectuera des présentations à l’occasion de..
31/08/202308:00BWExscientia to Present at Upcoming Investor Conferences in..
10/08/202308:00BWExscientia Business Update for Second Quarter and First Half..
03/08/202308:00BWExscientia to Report Second Quarter 2023 Financial Results..
18/07/202321:29BWエクセンシア、卵巣がんのプロスペクティブ観察研究を開始
18/07/202316:15BWExscientia startet prospektive Beobachtungsstudie zu..
18/07/202314:15BWExscientia lance une étude observationnelle prospective sur..
18/07/202308:00BWExscientia Initiates Prospective Observational Study in..
11/07/202305:22BW進行固形腫瘍におけるGTAEXS617の「ELUCIDATE」第1/2相試験に最初の患者を登録
10/07/202319:59BWErster Patient in Phase I/II „ELUCIDATE” Studie zur..
10/07/202314:32BWPremier patient recruté dans l'essai de Phase 1/2 «..
10/07/202308:00GLOBEGT Apeiron Announces Enrollment of First Patient in Phase..
30/06/202313:29BW英エクセンシア、技術リーダーシップチームの拡張を発表

Seu Histórico Recente

Delayed Upgrade Clock